The rare disease landscape has long been defined by delay, with families frequently facing 7–10 years before receiving a diagnosis. In recognition of Rare Disease Day, Ann Cave, President, Full-Service Agency, wrote an article for PM360 spotlighting how innovation and human insight are reshaping the rare disease landscape as well as how technology and empathy are helping shorten the long road to diagnosis and treatment for rare disease patients.
EVERSANA INTOUCH has spent more than 20 years working to close that gap, supporting nearly 150 rare disease brands and helping drive more than 300,000 rare disease prescriptions in a single year through smarter education and more personalized engagement.
Here are a few key insights from Ann on how to transform the rare disease journey:
1. Technology is the Accelerator
AI, real‑world data, and precision analytics are helping identify undiagnosed patients sooner, enabling them to reach the right healthcare providers faster and anticipate access barriers before they slow treatment.
2. Human Expertise is the Conductor
As Ann notes, technology alone isn’t enough. Rare disease experts — those who understand the emotional, financial and logistical realities families face — are essential to translating data into action that truly supports patients and caregivers.
3. Innovation + Empathy Drive Real‑World Impact
The most effective brands blend data-driven insight with deep empathy to deliver meaningful results.
For one rare disease brand, AI‑powered targeting was 76× more precise than disease prevalence — helping accelerate diagnoses and connect more families to answers.
The Opportunity Ahead
Nearly half of rare disease patients still don’t get clear answers. Empowered patients are using new tools to advocate for themselves, and the industry is recognizing that innovation paired with empathy is the only path forward. This isn’t just a rare disease aspiration — it’s a healthcare imperative.
Read the full article in PM360 to explore how innovation and intent can meaningfully transform the rare disease journey.